Priliximab

Priliximab (cMT 412) is a human-mouse chimeric anti-CD4 monoclonal antibody. It has been tested on patients with Crohn's disease and multiple sclerosis but has not yet received U.S. Food and Drug Administration licensing. The patent belongs to the biotechnology company Centocor.

单词	Priliximab
释义	Priliximab 英语百科 Priliximab Priliximab (cMT 412) is a human-mouse chimeric anti-CD4 monoclonal antibody. It has been tested on patients with Crohn's disease and multiple sclerosis but has not yet received U.S. Food and Drug Administration licensing. The patent belongs to the biotechnology company Centocor.
随便看	T Cell Antigen Receptor gamma Chain Gene Rearrangement T cell antigen receptor site T Cell Antigen Receptor Specificity T cell area T cell B cell interaction T Cell beta Chain Gene Rearrangement T cell chronic lymphocytic T cell chronic lymphocytic leukemia T cell conditioned medium T Cell delta Chain Gene Rearrangement t cell dependent T cell dependent antigen T celldependent antigen T cell depletion T cell derived factor T cell developmental defect T cell differentiation antigen T Cell Differentiation Antigens T cell enriched T cell epitope T Cell Epitopes t cell erythroderma t cell factor T Cell gamma Chain Gene Rearrangement T Cell Gene Rearrangement